LOTA S ZOTH Insider Trading $ZYME Zymeworks Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for LOTA S ZOTH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of LOTA S ZOTH. LOTA S ZOTH is Chief Financial Officer in MEDIMMUNE INC /DE ($MEDI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in NEWLINK GENETICS CORP ($NLNK) and Director in Orexigen Therapeutics, Inc. ($OREX) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Zymeworks Inc. ($ZYME) and CHIEF SCIENTIFIC OFFICER in Spark Therapeutics, Inc. ($ONCE) and Director in Spark Therapeutics, Inc. ($ONCE) and Director in 89bio, Inc. ($ETNB).

LOTA S ZOTH in Zymeworks Inc.

Trading Symbol: ZYME
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOTA S ZOTH: Director
Holdings: 0 shares
Latest Transaction: May 07 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of LOTA S ZOTH in Zymeworks Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ETNB, HPTX, GEB, NLNK, MEDI, OREX, ONCE, ZYME

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 07 2021ZYMEZymeworks Inc.Zoth Lota S.DirectorOption ExerciseA29.499,000265,4109,000
May 12 2020ZYMEZymeworks Inc.Zoth Lota S.DirectorOption ExerciseA35.499,000319,4109,000
May 08 2019ZYMEZymeworks Inc.Zoth Lota S.DirectorOption ExerciseA19.1110,000191,10010,000

Page:   1